Trial Profile
A phase II study of cetuximab in patients with unresectable or metastatic hepatocellular carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 07 Nov 2005 New trial record.